Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice

Search this Article

Author(s)

    • YAMAMOTO Ryuichiro
    • Department of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine
    • MATSUSHITA Masaki
    • Department of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine
    • KITOH Hiroshi
    • Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine
    • MASUDA Akio
    • Department of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine
    • ITO Mikako
    • Department of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine
    • KATAGIRI Takenobu
    • Division of Pathophysiology, Research Center for Genomic Medicine, Saitama Medical University
    • KAWAI Tatsushi
    • Department of Dental and Material Science, Aichi-Gakuin University School of Dentistry
    • ISHIGURO Naoki
    • Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine
    • OHNO Kinji
    • Department of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine

Journal

  • Journal of bone and mineral metabolism

    Journal of bone and mineral metabolism 31(1), 26-33, 2013-01-30

References:  57

Codes

  • NII Article ID (NAID)
    10031168834
  • NII NACSIS-CAT ID (NCID)
    AA10747551
  • Text Lang
    ENG
  • Article Type
    ART
  • ISSN
    09148779
  • Data Source
    CJP 
Page Top